A scientific statement from the European Society of Cardiology highlights early primary care interventions and cardiometabolic management to prevent heart failure before symptoms emerge
Most Recent Articles
Cost-Effectiveness of Generic Semaglutide and SGLT2 Inhibitors in Type 2 Diabetes
Generic semaglutide price reductions render dual GLP-1RA and SGLT2i therapy highly cost-effective for high-risk Canadian patients with type 2 diabetes.
Characterizing Cell-Type-Specific Autonomic Networks Within the Intrinsic Cardiac Nervous System
A landmark Cell study reveals that the heart's intrinsic nervous system contains distinct neuron populations essential for basal cardiac function and stress protection.
Selective Autophagy of Trapped PARP1 as a Therapeutic Target in Breast Cancer
A novel Nature Cell Biology study reveals that cancer cells hijack TEX264-mediated nucleophagy to clear trapped PARP1 and resist PARP inhibitor treatments.
Regulatory IgA B-Cell Mobilization Drives Therapeutic Success in Anti-CD20 Depletion
A multiomic study reveals that anti-CD20 B-cell depletion therapies in multiple sclerosis work by recruiting protective, gut-derived IgA B cells into the bloodstream and brain.